Arcturus Therapeutics Holdings Inc. Common Stock
Market Cap
160M
Short interest (Jul 15)
24.6%
Net Short (Jul 27 ): 0.1%
Borrow Fee
0.81%
↑ 13.2%
Available Shares
600K
↑ 35.7%
Price Chart
Company Overview
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.